ALGS
Price
$7.21
Change
-$0.17 (-2.30%)
Updated
Oct 17 closing price
13 days until earnings call
RLAY
Price
$6.64
Change
-$0.16 (-2.35%)
Updated
Oct 17 closing price
13 days until earnings call
Ad is loading...

ALGS vs RLAY

Header iconALGS vs RLAY Comparison
Open Charts ALGS vs RLAYBanner chart's image
Aligos Therapeutics
Price$7.21
Change-$0.17 (-2.30%)
Volume$17.39K
CapitalizationN/A
Relay Therapeutics
Price$6.64
Change-$0.16 (-2.35%)
Volume$1.09M
CapitalizationN/A
View a ticker or compare two or three
ALGS vs RLAY Comparison Chart
Loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALGS vs. RLAY commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGS is a Sell and RLAY is a Sell.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (ALGS: $7.21 vs. RLAY: $6.64)
Brand notoriety: ALGS and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALGS: 22% vs. RLAY: 40%
Market capitalization -- ALGS: $25.7M vs. RLAY: $1.15B
ALGS [@Biotechnology] is valued at $25.7M. RLAY’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGS’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • ALGS’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than ALGS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGS’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • ALGS’s TA Score: 5 bullish, 5 bearish.
  • RLAY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALGS is a better buy in the short-term than RLAY.

Price Growth

ALGS (@Biotechnology) experienced а +4.64% price change this week, while RLAY (@Biotechnology) price change was +0.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ALGS is expected to report earnings on Oct 31, 2024.

RLAY is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.15B) has a higher market cap than ALGS($25.7M). RLAY YTD gains are higher at: -39.691 vs. ALGS (-56.566). ALGS has higher annual earnings (EBITDA): -90.79M vs. RLAY (-367.86M). RLAY has more cash in the bank: 688M vs. ALGS (94.5M). ALGS has less debt than RLAY: ALGS (9.84M) vs RLAY (51.1M). RLAY has higher revenues than ALGS: RLAY (35.2M) vs ALGS (7.97M).
ALGSRLAYALGS / RLAY
Capitalization25.7M1.15B2%
EBITDA-90.79M-367.86M25%
Gain YTD-56.566-39.691143%
P/E RatioN/AN/A-
Revenue7.97M35.2M23%
Total Cash94.5M688M14%
Total Debt9.84M51.1M19%
TECHNICAL ANALYSIS
Technical Analysis
ALGSRLAY
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
ALGS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

ALGS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with STRO. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then STRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGS
1D Price
Change %
ALGS100%
-2.30%
STRO - ALGS
39%
Loosely correlated
-1.59%
RLAY - ALGS
31%
Poorly correlated
-2.35%
CNSP - ALGS
27%
Poorly correlated
-2.76%
TGTX - ALGS
27%
Poorly correlated
-2.29%
AGTX - ALGS
26%
Poorly correlated
N/A
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-2.35%
XNCR - RLAY
54%
Loosely correlated
-0.74%
BCYC - RLAY
45%
Loosely correlated
-2.80%
VCYT - RLAY
44%
Loosely correlated
-1.18%
TVTX - RLAY
43%
Loosely correlated
+1.11%
AXON - RLAY
42%
Loosely correlated
+0.15%
More